Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01051557
What this trial is testing

Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00301873
What this trial is testing

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Who this might be right for
Brain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies
Duke University 60
Very early researchStudy completedNCT02338037
What this trial is testing

Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors

Who this might be right for
Metastatic Malignant Neoplasm in the Adult BrainPrimary Brain Tumor
City of Hope Medical Center 8
Not applicableStudy completedNCT00999622
What this trial is testing

Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma

Who this might be right for
Brain and Central Nervous System TumorsInfection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 104
Testing effectiveness (Phase 2)Study completedNCT00671970
What this trial is testing

Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 57
Not applicableStudy completedNCT00595322
What this trial is testing

Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma

Who this might be right for
Brain CancerRecurrent Malignant GliomasPrimary Brain Tumor
Memorial Sloan Kettering Cancer Center 25
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Early research (Phase 1)Study completedNCT00064779
What this trial is testing

Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 18
Testing effectiveness (Phase 2)Looking for participantsNCT06047379
What this trial is testing

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Who this might be right for
Diffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more
Neonc Technologies, Inc. 134
Early research (Phase 1)Study completedNCT02238496
What this trial is testing

Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

Who this might be right for
Brain Tumor, RecurrentGlioblastomaAnaplastic Astrocytoma+2 more
Andrew B Lassman, MD 10
Testing effectiveness (Phase 2)WithdrawnNCT03868423
What this trial is testing

Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers

Who this might be right for
Advanced Malignant NeoplasmALK Fusion Protein ExpressionALK Gene Amplification+8 more
Sameek Roychowdhury
Testing effectiveness (Phase 2)Study completedNCT00004113
What this trial is testing

Temozolomide in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02885324
What this trial is testing

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaMalignant Brain Tumor+1 more
Indiana University 4
Early research (Phase 1)Study completedNCT02658981
What this trial is testing

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Who this might be right for
GlioblastomaGliosarcomaRecurrent Brain Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Testing effectiveness (Phase 2)Study completedNCT00006102
What this trial is testing

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeuroblastoma+3 more
National Cancer Institute (NCI) 200
Early research (Phase 1)WithdrawnNCT06137651
What this trial is testing

Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis

Who this might be right for
Breast CarcinomaMetastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the Leptomeninges
Northwestern University
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971501
What this trial is testing

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8
National Cancer Institute (NCI) 5
Early research (Phase 1)Ended earlyNCT02571530
What this trial is testing

Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer

Who this might be right for
Neoplasm Metastasis
Northwell Health 2
Not applicableStudy completedNCT00184353
What this trial is testing

Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.

Who this might be right for
Neoplasm Metastases
Norwegian University of Science and Technology 19
Not applicableStudy completedNCT06557967
What this trial is testing

Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment

Who this might be right for
Non-small Cell Lung CancerLung CancerMetastatic Cancer+1 more
Daiichi Sankyo 22,517
Next Page